| Literature DB >> 33881200 |
Teresa Stachowicz-Stencel1, Anna Synakiewicz1, Marianna Cornet2, Andrea Ferrari3, Marina Garassino4, Jordi Remon Masip5, Rod Julien6, Calogero Virgone7, Dominik T Schneider8, Ines B Brecht9, Tal Ben-Ami10, Ewa Bien1, Yves Reguerre11, Jan Godzinski12,13, Gianni Bisogno14, Daniel Orbach15, Sabine Sarnacki2.
Abstract
Thymic tumors are epithelial tumors arising from the anterior mediastinum and constitute 0.2-1.5% of all adult malignancies but are exceptional in pediatric population. Thymic epithelial tumors (TETs) encompass a variety of histologic subtypes associated with different clinical outcomes. Due to its rarity in children, TETs' management requires a multidisciplinary approach. However, prognosis remains still poor, especially among patients with thymic carcinoma. This study presents the internationally recognized recommendations for the diagnosis and treatment of thymic tumors in children and adolescents, established by the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) group within the EU-funded project Paediatric Rare Tumours Network - European Registry (PARTNER).Entities:
Keywords: EXPeRT; PARTNER; adolescents; children; guidelines; thymic carcinoma; thymic epithelial tumors; thymoma
Mesh：
Year: 2021 PMID： 33881200 DOI： 10.1002/pbc.29042
Source DB: PubMed Journal: Pediatr Blood Cancer ISSN： 1545-5009 Impact factor: 3.167